Deep gray matter T2 hypointensity correlates with disability in a murine model of MS

Journal of the Neurological Sciences

Volumn 282, Issue 1-2, 2009, Pages 34-38

  Pirko, Istvan ^a   Johnson, Aaron J ^a   Lohrey, Anne K ^a   Chen, Yi ^a   Ying, Jun ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Deep gray matter; EAE; Iron deposition; Magnetic resonance imaging; MRI; MS; Multiple sclerosis; Multiple sclerosis animal model; T2 hypointensity; Theiler's murine encephalitis virus; TMEV

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; ENCEPHALITIS VIRUS; GRAY MATTER; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THALAMUS NUCLEUS;

ANIMALS; BRAIN; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MICE; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX; THALAMUS; THEILOVIRUS; TIME FACTORS;

EID: 67349282356     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.013     Document Type: Article

References (38)

1. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N Engl J Med 343 13 (2000) 938-952
2. Lucchinetti C.F., Parisi J., and Bruck W. The pathology of multiple sclerosis. Neurol Clin 23 1 (2005) 77-105 [vi]
3. Kutzelnigg A., and Lassmann H. Cortical lesions and brain atrophy in MS. J Neurol Sci 233 1-2 (2005) 55-59
4. Pirko I., Lucchinetti C.F., Sriram S., and Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 68 9 (2007) 634-642
5. Zivadinov R., and Cox J.L. Neuroimaging in multiple sclerosis. Int Rev Neurobiol 79 (2007) 449-474
6. Zivadinov R., and Leist T.P. Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging 15 4 Suppl (2005) 10S-21S
7. Bakshi R., Dmochowski J., Shaikh Z.A., and Jacobs L. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 185 1 (2001) 19-26
8. Bakshi R., Benedict R.H., Bermel R.A., Caruthers S.D., Puli S.R., Tjoa C.W., et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 59 1 (2002) 62-68
9. Neema M., Stankiewicz J., Arora A., Dandamudi V.S., Batt C.E., Guss Z.D., et al. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 17 Suppl 1 (2007) 16S-21S
10. Kurtzke J.F. Historical and clinical perspectives of the Expanded Disability Status Scale. Neuroepidemiology 31 1 (2008) 1-9
11. Tjoa C.W., Benedict R.H., Weinstock-Guttman B., Fabiano A.J., and Bakshi R. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 234 1-2 (2005) 17-24
12. Zhang Y., Zabad R.K., Wei X., Metz L.M., Hill M.D., and Mitchell J.R. Deep grey matter "black T2" on 3 Tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 13 7 (2007) 880-883
13. Brass S.D., Benedict R.H., Weinstock-Guttman B., Munschauer F., and Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 12 4 (2006) 437-444
14. Bermel R.A., Puli S.R., Rudick R.A., Weinstock-Guttman B., Fisher E., Munschauer III F.E., et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 62 9 (2005) 1371-1376
15. Ge Y., Jensen J.H., Lu H., Helpern J.A., Miles L., Inglese M., et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 28 9 (2007) 1639-1644
16. Drayer B., Burger P., Hurwitz B., Dawson D., and Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?. AJR Am J Roentgenol 149 2 (1987) 357-363
17. Levine S.M., and Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 1012 (2004) 252-266
18. Forge J.K., Pedchenko T.V., and LeVine S.M. Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 63 25 (1998) 2271-2284
19. Pedchenko T.V., and LeVine S.M. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J Neuroimmunol 84 2 (1998) 188-197
20. Grant S.M., Wiesinger J.A., Beard J.L., and Cantorna M.T. Iron-deficient mice fail to develop autoimmune encephalomyelitis. J Nutr 133 8 (2003) 2635-2638
21. Mitchell K.M., Dotson A.L., Cool K.M., Chakrabarty A., Benedict S.H., and LeVine S.M. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult Scler 13 9 (2007) 1118-1126
22. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60 1 (2006) 12-21
23. Lassmann H., and Ransohoff R.M. The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol 25 3 (2004) 132-137
24. Sriram S., and Steiner I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 58 6 (2005) 939-945
25. Nelson A.L., Bieber A.J., and Rodriguez M. Contrasting murine models of MS. Int MS J 11 3 (2004) 95-99
26. Rodriguez M., Oleszak E., and Leibowitz J. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 7 4 (1987) 325-365
27. Katz-Levy Y., Neville K.L., Girvin A.M., Vanderlugt C.L., Pope J.G., Tan L.J., et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 104 5 (1999) 599-610
28. Brahic M. Theiler's virus infection of the mouse, or: of the importance of studying animal models. Virology 301 1 (2002) 1-5
29. Pirko I., Nolan T.K., Holland S.K., and Johnson A.J. Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model. Radiology 246 3 (2008) 790-795
30. Pirko I., Fricke S.T., Johnson A.J., Rodriguez M., and Macura S.I. Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx 2 2 (2005) 250-264
31. Robb R.A. The biomedical imaging resource at Mayo Clinic. IEEE Trans Med Imaging 20 9 (2001) 854-867
32. Robb R.A. 3-D visualization in biomedical applications. Annu Rev Biomed Eng 1 (1999) 377-399
33. Bowern N., Ramshaw I.A., Clark I.A., and Doherty P.C. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med 160 5 (1984) 1532-1543
34. Willenborg D.O., Bowern N.A., Danta G., and Doherty P.C. Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen. J Neuroimmunol 17 2 (1988) 127-135
35. Wylezinska M., Cifelli A., Jezzard P., Palace J., Alecci M., and Matthews P.M. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 60 12 (2003) 1949-1954
36. Cifelli A., Arridge M., Jezzard P., Esiri M.M., Palace J., and Matthews P.M. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52 5 (2002) 650-653
37. Fabiano A.J., Sharma J., Weinstock-Guttman B., Munschauer III F.E., Benedict R.H., Zivadinov R., et al. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimaging 13 4 (2003) 307-314
38. Houtchens M.K., Benedict R.H., Killiany R., Sharma J., Jaisani Z., Singh B., et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 69 12 (2007) 1213-1223